National / Science & Health Nov 10, 2021
Japan OKs administration of Pfizer COVID-19 vaccine booster shots
The rollout of third injections will begin with medical personnel from December.
Japan OKs administration of Pfizer COVID-19 vaccine booster shots
The rollout of third injections will begin with medical personnel from December.
Pfizer applies for COVID-19 vaccine approval for kids age 5 to 11 in Japan
If approved by the health ministry, Pfizer's shot will be the first to be administered to children under 11 in Japan.
South Korea to purchase 70,000 courses of new Pfizer COVID-19 pill
Pfizer has said trial results showed that its Paxlovid pill reduced by 89% the risk of hospitalization or death in some patients.
COVID-19 drugs will change the way we live with the virus
New COVID-19 drug approvals couldn’t be timelier as hospitals face massive backlogs of delayed procedures.
Pfizer results open door to new chapter for COVID treatments
The world needs an easy-to-take COVID-19 treatment. Pfizer Inc.’s and Merck & Co. Inc.’s new pills may be just that. But questions remain about their safety and how well they will work.
Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%
The drugmaker claims "overwhelming efficacy” and plans to submit their findings for emergency authorization as soon as possible.
Pfizer won the first round, but Moderna sees final victory ahead
Pfizer has been first across the finish line in nearly every leg of the COVID-19 vaccine race, but Moderna executives say their company’s mRNA technology gives it an advantage.
Pfizer to seek OK for use of COVID-19 shot in children in Japan age 5 to 11
The government is hinting that it will act swiftly to make the vaccine available to children in that demographic.
Japan may recommend Pfizer's COVID-19 shot over Moderna's for men under 30
Even as concerns grow about higher rates of myocarditis among young men who got the Moderna shot, the risk of developing the heart condition is still much lower than after getting COVID-19.
Japan secures 120 million extra Pfizer vaccine doses for next year
The country decided in September to start administering third shots of coronavirus vaccines by the end of this year to increase protection.
Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11
The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.
China's vaccine diplomacy drive falters as recipients turn to western shots
In the early days of COVID-19 vaccine rollouts, Chinese shots saved countless lives. But as the Western stranglehold on mRNA supplies loosens, a clear preference has emerged.